Perceptive Advisors LLC Amicus Therapeutics, Inc. Transaction History

Perceptive Advisors LLC

$2.39 Billion
Q1 2025

A detailed history of Perceptive Advisors LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Perceptive Advisors LLC holds 21,464,527 shares of FOLD stock, worth $128 Million. This represents 7.33% of its overall portfolio holdings.

Number of Shares

21,464,527

Previous 24,245,952 11.47%

Holding current value

$128 Million

Previous $228 Million 23.31%

% of portfolio

7.33%

Previous 7.62%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$8.16 - $9.85 $22.7 Million - $27.4 Million	-2,781,425 Reduced 11.47%	21,464,527 $175 Million
Q4 2024 Feb 14, 2025	SELL	$9.36 - $12.01 $35.7 Million - $45.8 Million	-3,811,504 Reduced 13.58%	24,245,952 $228 Million
Q4 2023 Feb 14, 2024	BUY	$9.97 - $14.52 $3.63 Million - $5.29 Million	364,539 Added 1.32%	28,057,456 $398 Million
Q3 2023 Nov 14, 2023	BUY	$11.78 - $13.86 $353,400 - $415,800	30,000 Added 0.11%	27,692,917 $337 Million
Q1 2023 May 15, 2023	BUY	$10.91 - $13.54 $218,200 - $270,800	20,000 Added 0.07%	27,662,917 $307 Million
Q4 2022 Feb 14, 2023	BUY	$9.89 - $12.7 $2.67 Million - $3.43 Million	270,000 Added 0.99%	27,642,917 $338 Million
Q3 2022 Nov 14, 2022	BUY	$9.82 - $12.75 $4.69 Million - $6.09 Million	477,385 Added 1.77%	27,372,917 $286 Million
Q2 2022 Aug 15, 2022	SELL	$6.23 - $11.12 $4.11 Million - $7.34 Million	-660,313 Reduced 2.4%	26,895,532 $289 Million
Q1 2022 May 16, 2022	BUY	$7.89 - $12.48 $7.86 Million - $12.4 Million	996,402 Added 3.75%	27,555,845 $261 Million
Q3 2021 Nov 15, 2021	BUY	$8.74 - $11.84 $30 Million - $40.7 Million	3,438,114 Added 14.87%	26,559,443 $254 Million
Q2 2021 Aug 16, 2021	BUY	$8.71 - $10.72 $2.26 Million - $2.79 Million	260,000 Added 1.14%	23,121,329 $223 Million
Q1 2021 May 17, 2021	SELL	$9.2 - $23.86 $20.7 Million - $53.7 Million	-2,250,719 Reduced 8.96%	22,861,329 $226 Million
Q4 2020 Feb 16, 2021	SELL	$13.47 - $24.89 $134,700 - $248,900	-10,000 Reduced 0.04%	25,112,048 $580 Million
Q3 2020 Nov 16, 2020	SELL	$12.89 - $15.89 $777,473 - $958,421	-60,316 Reduced 0.24%	25,122,048 $355 Million
Q1 2020 May 15, 2020	BUY	$6.63 - $11.16 $331,500 - $558,000	50,000 Added 0.2%	25,182,364 $233 Million
Q4 2019 Feb 14, 2020	BUY	$7.48 - $10.75 $3.91 Million - $5.62 Million	522,664 Added 2.12%	25,132,364 $245 Million
Q3 2019 Nov 14, 2019	BUY	$8.02 - $13.25 $24.9 Million - $41.1 Million	3,100,214 Added 14.41%	24,609,700 $197 Million
Q2 2019 Aug 14, 2019	SELL	$10.96 - $14.4 $1.42 Million - $1.87 Million	-130,000 Reduced 0.6%	21,509,486 $268 Million
Q1 2019 May 15, 2019	BUY	$10.04 - $13.92 $9.19 Million - $12.7 Million	915,062 Added 4.42%	21,639,486 $294 Million
Q4 2018 Feb 14, 2019	BUY	$8.38 - $13.44 $251,400 - $403,200	30,000 Added 0.14%	20,724,424 $192 Million
Q3 2018 Nov 14, 2018	BUY	$11.6 - $16.54 $7.77 Million - $11.1 Million	670,000 Added 3.35%	20,694,424 $250 Million
Q1 2018 May 15, 2018	BUY	$13.76 - $17.12 $29.4 Million - $36.6 Million	2,135,827 Added 11.94%	20,024,424 $301 Million
Q3 2017 Nov 14, 2017	BUY	$11.74 - $15.78 $210 Million - $282 Million	17,888,597	17,888,597 $270 Million

Others Institutions Holding FOLD

# of Institutions

314

Shares Held

319M

Call Options Held

378K

Put Options Held

575K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $1.67B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.

Account

Perceptive Advisors LLC Amicus Therapeutics, Inc. Transaction History